From discovery to delivery: examining US health innovation and performance in a global context

Are current approaches to measuring health system performance sufficiently capturing the role of innovation? For decades, cross-country comparisons have relied on static indicators such as life expectancy, spending and hospital capacity. While essential, these measures offer only a partial view. They rarely reflect how systems adapt to change, embed new technologies or translate scientific breakthroughs into meaningful improvements in access, equity and outcomes. From discovery to delivery: examining US health innovation and performance in a global context addresses this gap. Supported by The Cigna Group, the report introduces the Health Systems Innovation-Integration Matrix, a new framework that evaluates not only how countries generate innovation, but how effectively they integrate and scale it within their health systems. It also frames the opportunity for the US to ensure its position at the frontier of health innovation translates into meaningful health gains for all.
Whitepaper
Learn how innovation can be more effectively measured, integrated and scaled to drive stronger health system performance. This whitepaper provides a practical framework for understanding where the US stands globally, and what policymakers, employers and health leaders can do to translate innovation into meaningful, equitable health gains.

Expert Articles
Read two articles from leading experts in the field to explore how health systems can generate high-value innovation and how innovation should be more effectively compared across countries. Together, they offer practical insights for strengthening both innovation strategy and performance measurement.

How to compare innovation across health systems
As health systems grapple with mounting pressures and rapid technological change, assessing their performance demands a rethink.

How to create an innovation strategy to achieve a high-value health system
Health systems are strained by changing disease patterns, constrained public finances, political cross-winds and rapid technological change.
The Cigna Group’s David Brailer on the next big shifts in healthcare
